Arno Therapeutics (OTCMKTS:ARNI) Stock Passes Above 50 Day Moving Average – Time to Sell?

Arno Therapeutics, Inc. (OTCMKTS:ARNI)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares.

Arno Therapeutics Trading Down 100.0%

Arno Therapeutics Company Profile

Arno Therapeutics, Inc (OTCMKTS:ARNI) is a development‐stage biopharmaceutical company focused on the research and development of targeted therapeutics for oncology indications and rare genetic disorders. The company’s mission is to apply innovative biologic and protein engineering platforms to create therapies that address significant unmet medical needs in cancer and inherited metabolic conditions.

Arno’s pipeline centers on antibody‐based drug conjugates and recombinant fusion proteins designed to selectively target tumor cells or restore deficient enzyme activity in rare diseases.